ADAM10 is upregulated in melanoma metastasis compared with primary melanoma. - Wikidata - wikimedia - TriplyDB

ADAM10 is upregulated in melanoma metastasis compared with primary melanoma.

ADAM10 is upregulated in melanoma metastasis compared with primary melanoma.

http://www.wikidata.org/entity/Q35010009

about

Clinical significance of ADAM10 expression in laryngeal carcinoma.PAX2 regulates ADAM10 expression and mediates anchorage-independent cell growth of melanoma cells Soluble E-cadherin: more than a symptom of disease.Inhibiting adenoid cystic carcinoma cells growth and metastasis by blocking the expression of ADAM 10 using RNA interference.The Roles of ADAMs Family Proteinases in Skin Diseases Prostaglandins in cancer cell adhesion, migration, and invasion ADAM10: a new player in breast cancer progression?Notch1 Autoactivation via Transcriptional Regulation of Furin, Which Sustains Notch1 Signaling by Processing Notch1-Activating Proteases ADAM10 and Membrane Type 1 Matrix Metalloproteinase The use of an in vitro 3D melanoma model to predict in vivo plasmid transfection using electroporation.Effects of ADAM10 upregulation on progression, migration, and prognosis of nasopharyngeal carcinoma.L1cam promotes tumor progression and metastasis and is an independent unfavorable prognostic factor in gastric cancer The ADAMs family of proteases as targets for the treatment of cancer.Reduced Proteolytic Shedding of Receptor Tyrosine Kinases Is a Post-Translational Mechanism of Kinase Inhibitor Resistance ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis.Galectin-9 is a suppressor of T and B cells and predicts the immune modulatory potential of mesenchymal stromal cell preparations Desmoplasia: not always a bad thing.Tetraspanin protein contributions to cancer.Identification of Nidogen 1 as a lung metastasis protein through secretome analysis.L1 cell adhesion molecule as a therapeutic target in cancer.Effect of A disintegrin and metalloproteinase 10 gene silencing on the proliferation, invasion and migration of the human tongue squamous cell carcinoma cell line TCA8113.ADAM10 correlates with uveal melanoma metastasis and promotes in vitro invasion.ADAM10 regulates proliferation, invasion, and chemoresistance of bladder cancer cells.ADAM 10 is over expressed in oral squamous cell carcinoma and contributes to invasive behaviour through a functional association with αvβ6 integrin.Multi-omics Analysis of Serum Samples Demonstrates Reprogramming of Organ Functions Via Systemic Calcium Mobilization and Platelet Activation in Metastatic Melanoma.ADAM10 overexpression confers resistance to doxorubicin-induced apoptosis in hepatocellular carcinoma.MicroRNA-145 targets the metalloprotease ADAM17 and is suppressed in renal cell carcinoma patients ADAM12-L confers acquired 5-fluorouracil resistance in breast cancer cells The disintegrin/metalloproteinase Adam10 is essential for epidermal integrity and Notch-mediated signaling.Aberrant ADAM10 expression correlates with osteosarcoma progression.Regulation of ADAM10 by miR-140-5p and potential relevance for Alzheimer's disease.Insulin-like growth factor-1 activates different catalytic subunits p110 of PI3K in a cell-type-dependent manner to induce lipogenesis-dependent epithelial-mesenchymal transition through the regulation of ADAM10 and ADAM17.The B7 Family Member B7-H6: a New Bane of Tumor.TSPAN15 interacts with BTRC to promote oesophageal squamous cell carcinoma metastasis via activating NF-κB signaling.The transcription factor PAX2 regulates ADAM10 expression in renal cell carcinoma.A disintegrin and metalloprotease (ADAM)10 is highly expressed in hepatocellular carcinoma and is associated with tumour progression.High percentage of ADAM-10 positive melanoma cells correlates with paucity of tumor-infiltrating lymphocytes but does not predict prognosis in cutaneous melanoma patients.Cellular sheddases are induced by Merkel cell polyomavirus small tumour antigen to mediate cell dissociation and invasiveness

P2860

Q33597779-28991314-A83A-4559-953E-1F8ED9EA356F Q34005367-F3DDA6F6-7258-4E7E-B571-7E2934610F26 Q34279705-9F49C2A9-6608-4FDB-99EC-B661A602EC44 Q34473664-425FB3BD-FD24-48F9-9964-57EC2BEB68DE Q34669802-25B93870-AE35-4BC2-9272-5884A6F75C5F Q35821653-21D5F815-DB3C-49B6-B21B-134339659CAE Q36081396-CFB25733-C316-490E-9CD5-3E0734F0B813 Q36109377-2CB0D281-55E5-4208-AFE9-97F187D74139 Q36303149-3274093D-96E2-4A40-9CF6-2DFCC9CBCAFD Q36467413-010347BD-8197-444F-ADCA-A18E36EAA941 Q37028791-5CFEFB6C-4147-4B72-A369-698AF290F798 Q37216972-A9AD3E20-76C3-4800-8760-A1A376F3FB07 Q37380418-C06BE0DC-8EF3-49CC-8374-F86FAE96319E Q37591124-0E0285AA-D39C-48BE-964E-8690F0A7B231 Q37667547-BFD9C153-6D1D-4F3B-8140-E1B3B784FD99 Q37780799-4F71339F-69F2-405A-92CC-449E542EDEFF Q37856398-4D3E60DB-11EC-4EAB-80AF-BFBFDA2FF2CB Q38615448-612D0ADD-BDC5-485D-83BB-7C7548274F1D Q38701631-A51297AF-CD61-47E4-B21C-2E4967975560 Q38946216-D8DE34AD-BCC1-4116-833B-8B18F5D7F403 Q38965918-AD0CC727-5E8D-4382-807E-64AB37CE1948 Q38984070-92C53A24-9D81-4718-8687-6B32F21C46E6 Q39093483-E8A45E41-67E4-44B6-A4EA-8B2B212A4E02 Q39159735-3F54F063-457D-42FA-9E3C-17A9824F22AE Q39348959-D0AB4908-E6F6-4CD0-B28C-844D45C0AD3D Q41412889-7FD70A9B-8EA8-4AD3-A2EB-399A5AF4D53E Q41548025-DF0CDD50-1172-4984-B20E-31AF8DC55807 Q41602986-1C870BFC-335D-466A-9A44-0358CC79E295 Q41982806-1EF86C07-3E3B-451E-8FA9-BA81378F3F0A Q47908768-E214D1BF-88C4-43F8-85C4-2BF3240F8BCC Q47936787-38A18104-8449-4B94-9991-D104444E6D5B Q48098708-D5EA9A84-E906-47DC-941D-8C69A47428B9 Q52590985-51CE3AAB-F6C5-4B20-A440-57B8C1E6B77A Q53222639-F7660DCF-6A8B-46CB-A976-9B0EE41650A7 Q54216177-5C6E7E4B-4747-401F-B735-401E3D3AD69C Q54310179-23BFC1BF-41A0-4837-924F-56567AAE8657 Q58761272-522A9B66-09B6-4047-A361-CE47B210F73A

P2860

ADAM10 is upregulated in melanoma metastasis compared with primary melanoma.

http://www.wikidata.org/entity/Q35010009

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

ADAM10 is upregulated in melanoma metastasis compared with primary melanoma.

@ast

ADAM10 is upregulated in melanoma metastasis compared with primary melanoma.

@en

type

label

ADAM10 is upregulated in melanoma metastasis compared with primary melanoma.

@ast

ADAM10 is upregulated in melanoma metastasis compared with primary melanoma.

@en

prefLabel

ADAM10 is upregulated in melanoma metastasis compared with primary melanoma.

@ast

ADAM10 is upregulated in melanoma metastasis compared with primary melanoma.

@en

P1433

Q35010009-49896B96-E8D4-496F-B547-9AA3C8DCE1C1

P1476

Q35010009-7841FD82-2C89-49A7-9481-7DB767B12B03

P2093

Q35010009-01FDF945-3AB7-4562-9555-FC785AC9274D

Q35010009-02B83852-08FA-4337-A7F8-0D6E51A0F3F6

Q35010009-1E680024-3A09-40E8-9669-6EA06805E260

Q35010009-41FC9C78-8C41-4BC9-8F1E-099A1FC4D759

Q35010009-5557EFAA-6D19-47C8-88FB-34C52EA22409

Q35010009-74C75E27-66B1-4923-8086-EB62BCF57092

Q35010009-902C71D3-12FB-41DF-8803-3344AB5F36F1

Q35010009-CD90C71C-C50B-4BB4-8604-7530188E1D0A

Q35010009-D4BE07DA-7824-4545-81A0-841DC9CBEC9D

Q35010009-E4D87B04-E1B8-46AA-A6DB-97A92BF5EC55

P2888

Q35010009-BAA8D35B-EEC1-4A13-B528-D881B148C84D

P304

Q35010009-52CE5111-1DDE-4202-A75F-D6C15D4F1F00

P31

Q35010009-9209FE70-714B-40B2-ABE3-0A4A7FF761AD

P356

Q35010009-59C3B15E-3F33-4E89-B1F0-FCA4492E66F9

P407

Q35010009-1F3A871A-4062-4B93-82D0-5E6BB915692E

P433

Q35010009-10802591-BA57-4108-881C-ACBCCE8E9C5B

P478

Q35010009-0373D57B-5BE6-4727-967C-24185071BD9D

P50

Q35010009-19328D6E-261F-4D66-B791-589590AE3EDC

Q35010009-31C996FB-8F80-4089-9B1D-2CA57C910B19

P577

Q35010009-9364DF3D-AD2E-4AA6-8418-4B93924EEFD1

P5875

Q35010009-8E3CBCA2-F57D-41CE-9663-27635131B688

P698

Q35010009-9AD345C0-295B-4481-B99F-F40919FA5210

P356

P1433

Journal of Investigative Dermatology

P1476

ADAM10 is upregulated in melanoma metastasis compared with primary melanoma

@en

P2093

Anja Schramme

http://www.w3.org/2001/XMLSchema#string

Daniel Oxmann

http://www.w3.org/2001/XMLSchema#string

Daniela Mihic-Probst

http://www.w3.org/2001/XMLSchema#string

Josef Pfeilschifter

http://www.w3.org/2001/XMLSchema#string

Jörg Reichrath

http://www.w3.org/2001/XMLSchema#string

Paul Gutwein

http://www.w3.org/2001/XMLSchema#string

Peter Altevogt

http://www.w3.org/2001/XMLSchema#string

Reinhard Dummer

http://www.w3.org/2001/XMLSchema#string

Sascha Keller

http://www.w3.org/2001/XMLSchema#string

Shin T Oh

http://www.w3.org/2001/XMLSchema#string

P2888

P304

763-773

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/JID.2009.335

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

130

http://www.w3.org/2001/XMLSchema#string

P50

Mohamed S Abdel-Bakky

P577

2009-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38044158

http://www.w3.org/2001/XMLSchema#string

P698

19865098

http://www.w3.org/2001/XMLSchema#string